Trial intelligence / Profile preview

Nebulized Dexmedetomidine for Gag Reflex in Pediatric Endoscopy

NCT06218797Completed

Sponsor
Ondokuz Mayıs University
Start
Jan 2024
Primary completion
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of dexmedetomidine in Procedural sedation (PS) (2 arms), sponsored by Ondokuz Mayıs University. Primary endpoint: Gag reflex suppression up to 1 hour. Started Jan 2024; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

Procedural sedation (PS)

Beyond the preview

Go deeper on NCT06218797.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06218797.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call